Evidence map›Paper›PMID 39225086›Full record

ArticleAging cell2024

Fkbp5 gene deletion: Circadian rhythm profile and brain proteomics in aged mice.

Niat T Gebru, Jennifer Guergues, Laura A Verdina, Jessica Wohlfahrt, Shuai Wang, Debra S Armendariz, Marsilla Gray, David Beaulieu-Abdelahad, Stanley M Stevens, Danielle Gulick and 1 more

Abstract read
In one paragraph

Article in Aging cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Hsp90: Bringing it all together.Cell stress & chaperones · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Niat T GebruByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.ORCID 0000-0002-5406-1920
Jennifer GuerguesDepartment of Molecular Biosciences, University of South Florida, Tampa, Florida, USA.
Laura A VerdinaByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
Jessica WohlfahrtDepartment of Molecular Biosciences, University of South Florida, Tampa, Florida, USA.
Shuai WangByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
Debra S ArmendarizByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
Marsilla GrayByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
David Beaulieu-AbdelahadByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
Stanley M StevensDepartment of Molecular Biosciences, University of South Florida, Tampa, Florida, USA.
Danielle GulickByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.
Laura J BlairByrd Alzheimer's Center and Research Institute, Tampa, Florida, USA.ORCID 0000-0002-4981-5564

Funding

The Hsp90 cochaperone FKBP51 regulates tau structure and functionR01NS073899 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI Laura J Blair · 2011 to 2026
$6.9M
Controlling FKBP51 for the treatment of PTSDI01BX004626 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI Laura J Blair · 2020 to 2026
–
Alzheimer's Association AARG-22-974562BLRD VA I01 BX004626NINDS NIH HHS R01 NS073899
6 · The paper itself

Abstract

FKBP51, also known as FK506-binding protein 51, is a molecular chaperone and scaffolding protein with significant roles in regulating hormone signaling and responding to stress. Genetic variants in FKBP5, which encodes FKBP51, have been implicated in a growing number of neuropsychiatric disorders, which has spurred efforts to target FKBP51 therapeutically. However, the molecular mechanisms and sub-anatomical regions influenced by FKBP51 in these disorders are not fully understood. In this study, we aimed to examine the impact of Fkbp5 ablation using circadian phenotyping and molecular analyses. Our findings revealed that the lack of FKBP51 did not significantly alter circadian rhythms, as detected by wheel-running activity, but did offer protection against stress-mediated disruptions in rhythmicity in a sex-dependent manner. Protein changes in Fkbp5 KO mice, as measured by histology and proteomics, revealed alterations in a brain region- and sex-dependent manner. Notably, regardless of sex, aged Fkbp5 KOs showed elevated MYCBP2, FBXO45, and SPRYD3 levels, which are associated with neuronal-cell adhesion and synaptic integrity. Additionally, pathways such as serotonin receptor signaling and S100 family signaling were differentially regulated in Fkbp5 KO mice. Weighted protein correlation network analysis identified protein networks linked with synaptic transmission and neuroinflammation. The information generated by this work can be used to better understand the molecular changes in the brain during aging and in the absence of Fkbp5, which has implications for the continued development of FKBP51-focused therapeutics for stress-related disorders.

Indexed as

BrainCircadian RhythmMice, KnockoutProteomicsTacrolimus Binding ProteinsAgingAnimalsFemaleGene DeletionMaleMiceMice, Inbred C57BLTacrolimus Binding Protein 5Tacrolimus Binding Protein 5Tacrolimus Binding ProteinsagingFKBP51neuroinflammationneuropsychiatric disordersproteomicsstress responsesynaptic transmission

Identifiers

PMID39225086
PMCPMC11634734

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.